Ranbaxy Laboratories Limited

🇨🇷Costa Rica
Ownership
-
Established
1996-08-30
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: PLENDIL®
Drug: Felodipine
First Posted Date
2014-12-30
Last Posted Date
2014-12-30
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
48
Registration Number
NCT02327247

Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Minocycline hydrochloride
First Posted Date
2014-12-09
Last Posted Date
2014-12-09
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
18
Registration Number
NCT02312609

Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Minocycline hydrochloride
First Posted Date
2014-12-09
Last Posted Date
2014-12-09
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
28
Registration Number
NCT02312297

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Felodipine (Plendil®)
Drug: Felodipine
First Posted Date
2014-12-08
Last Posted Date
2014-12-08
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
80
Registration Number
NCT02311530

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: ANTARA® (fenofibrate)
Drug: fenofibrate
First Posted Date
2014-12-03
Last Posted Date
2014-12-03
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
24
Registration Number
NCT02306902

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: ANTARA® (fenofibrate)
Drug: Fenofibrate
First Posted Date
2014-12-03
Last Posted Date
2014-12-03
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
48
Registration Number
NCT02306889

Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Valsartan
First Posted Date
2014-07-22
Last Posted Date
2014-07-22
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
36
Registration Number
NCT02197442
Locations
🇮🇳

Lambda Therapeutic Research Ltd.,, Ahmedabad, Gujarat, India

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Valsartan
First Posted Date
2014-07-22
Last Posted Date
2014-07-22
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT02197494
Locations
🇮🇳

Lambda Therapeutic Research Ltd., Navi Mumbai, Maharashtra, India

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Pantoprazole
First Posted Date
2012-08-01
Last Posted Date
2012-08-01
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT01654718
Locations
🇮🇳

Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Pantoprazole
First Posted Date
2012-08-01
Last Posted Date
2012-08-01
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
80
Registration Number
NCT01654705
Locations
🇮🇳

Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy